ADMA metabolism and clearance (Q36381017)

13 August 2017

1 reference

title

ADMA metabolism and clearance (English)

1 reference

13 August 2017

Tom Teerlink

1

1 reference

PubMed ID

16444872

13 August 2017

language of work or name

1 reference

1 July 2005

1 reference

13 August 2017

1 reference

13 August 2017

10 Suppl 1

1 reference

13 August 2017

S73-81

1 reference

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

13 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

A proteomic analysis of arginine-methylated protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Spliceosome Sm proteins D1, D3, and B/B' are asymmetrically dimethylated at arginine residues in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Arginine methylation of RNA helicase a determines its subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Fenofibrate increases the L-arginine:ADMA ratio by increase of L-arginine concentration but has no effect on ADMA concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

The anti-Sm immune response in autoimmunity and cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Molecular biology: no exception to reversibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Human PAD4 regulates histone arginine methylation levels via demethylimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Histone deimination antagonizes arginine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Protein degradation and protection against misfolded or damaged proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Ubiquitin-independent proteolytic functions of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Asymmetrical dimethylarginine: the Uber marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

ADMA and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Effect of endogenous estrogen on endothelial function in women with coronary heart disease and its mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Nitric Oxide Synthesis Requires Activity of the Cationic and Neutral Amino Acid Transport System y+L in Human Umbilical vein Endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Acute Escherichia coli endotoxaemia decreases the plasma l-arginine/asymmetrical dimethylarginine ratio in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Urinary excretion of methylarginine in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

The transplanted liver graft is capable of clearing asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM597OA

10.1191/1358863X05VM597OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16444872